Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12
Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum]
Authors Müllerová H , Landis SH, Aisanov Z , Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM , van der Molen T, Oh YM , Tabberer M, Han MK
Received 27 January 2017
Accepted for publication 27 January 2017
Published 15 March 2017 Volume 2017:12 Pages 859—860
Müllerová H, Landis SH, Aisanov Z, et al. Int J Chron Obstruct Pulmon Dis. 2016;11:881–890.
On page 882, right column, second paragraph, the sentence “The primary hypotheses were addressed using the PAM-13,2 and Morisky Medication Adherence Scale (MMAS)-8.18 should have read “The primary hypotheses were addressed using the PAM-13,2 and Morisky Medication Adherence Scale (MMAS)-8.18,40,41
On page 882, right column, last paragraph, the sentence “Adherence is classified as low (score 1–5), medium (score 6–7), or high (score 8) according to the overall score.” should read “Adherence is classified as low (score ,6), medium (score 6 to ,8), or high (score 8) according to the overall score.”
On page 886, Table 3, the copyright statement “Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.18,40,41” was not included in the Note section.
Read the original article
© 2017 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.